CME Group price target lowered to $307 from $309 at Raymond James

Raymond James analyst Patrick O’Shaughnessy lowered the firm’s price target on CME Group (CME) to $307 from $309 and keeps an Outperform rating on the shares ahead of the Q3 earnings report. CME’s suite of risk management tools positions the firm well in a volatile global macroeconomic and geopolitical backdrop, though when volatility subsides as it did during the past few months, CME’s futures volumes can moderate and lead to near-term downside estimate revisions, the analyst tells investors in a research note.